Lavie Bio
Biotechnology ResearchIsrael11-50 Employees
lavie-bio is an innovative company promoting food quality and agricultural sustainability through the introduction of microbiome based ag-biological products
Recent Acquisition Lavie Bio has been acquired by ICL, a major player in the agricultural industry, which could open up opportunities for selling complementary biological solutions and expanding distribution channels within their global network.
Strategic Partnerships Lavie Bio's collaborations with companies like Syngenta, WinField United, and Ceres Global Ag demonstrate its strong market presence and potential to leverage these relationships to introduce new bio-inoculants and biostimulant products to diverse agricultural markets.
Innovation Funding The company has received government grants for advancing technologies like the microfermentor, indicating a focus on innovative R&D that can lead to new, scalable ag-biological products for sale within targeted crop segments facing abiotic stresses.
Product Focus Lavie Bio specializes in microbial-based bio-inoculants such as Yalos, addressing crop stress and pest challenges, presenting a sales opportunity for expanding adoption among farmers seeking sustainable and effective biological alternatives.
Market Expansion With active global partnerships in North America and ongoing product development, Lavie Bio is positioned to grow its presence in key agricultural markets, offering potential sales channels for biological solutions that meet increasing demand for eco-friendly farming practices.
Lavie Bio uses 8 technology products and services including LiteSpeed Cache, Open Graph, Microsoft 365, and more. Explore Lavie Bio's tech stack below.
| Lavie Bio Email Formats | Percentage |
| First.Last@lavie-bio.com | 44% |
| FirstL@lavie-bio.com | 6% |
| First.Last@lavie-bio.com | 44% |
| FirstL@lavie-bio.com | 6% |
Biotechnology ResearchIsrael11-50 Employees
lavie-bio is an innovative company promoting food quality and agricultural sustainability through the introduction of microbiome based ag-biological products
Lavie Bio's revenue is estimated to be in the range of $1M$10M
Lavie Bio's revenue is estimated to be in the range of $1M$10M